alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
| **Derivative Financial Instruments and Risk Management (Details 3) - USD ($) $ in Millions** | Mar. 31, 2016 | Dec. 31, 2015 |
|----------------------------------------------------------------------------------------------|---------------|---------------|
| **Derivative**                                                                               |          |          |
| Derivative instruments, notional amount                                                      | $ 3,950       | $ 3,540       |

| X                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Definition
Aggregate notional amount specified by the derivative(s). Expressed as an absolute value.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Article 12 -Section 13 -Sentence Column B
+ Details**Name:**invest_DerivativeNotionalAmount**Namespace Prefix:**invest_**Data Type:**xbrli:monetaryItemType**Balance Type:**na**Period Type:**instant |
| X                                                                                                                                                                                                                                                                                                                                                                                                           |
|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details**Name:**us-gaap_DerivativeLineItems**Namespace Prefix:**us-gaap_**Data Type:**xbrli:stringItemType**Balance Type:**na**Period Type:**duration |
Order entered April 13, 2015

In The

Court of Appeals 

Fifth District of Texas at Dallas 

No. 05-14-00974-CR

THE STATE OF TEXAS, Appellant

V.

AMBER LASHBROOK, Appellee

On Appeal from the 292nd Judicial District Court

Dallas County, Texas

Trial Court Cause No. F12-23860

ORDER

Appellee’s April 10, 2015 motion for extension of time in which to file her brief is 

GRANTED. Appellee is ORDERED to file her brief on or before May 11, 2015. Any 

additional requests for extension are discouraged.

/s/ MOLLY FRANCIS 

PRESIDING JUSTICE
#### Lewis C. Lendrum, Appellant, v. Ralph Wolford, Commissioner, etc., Respondent.

Judgment and order affirmed, with costs. Opinion by

Bockes, J.
Exhibit 32.1




Certification of Chief Executive Officer


Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002




Solely for the purpose of complying with 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, I, the undersigned Chief Executive Officer of Alliance Pharmaceutical Corp. (the “Company”), hereby certify, based on my knowledge, that the Annual Report on Form 10-K of the Company for the year ended June 30, 2009 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities and Exchange Act of 1934 and that information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.




Date: May 21, 2010






By:
/s/ Duane J. RothDuane J. RothChief Executive Officer


A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to Alliance Pharmaceutical Corp. and will be retained by Alliance Pharmaceutical Corp. and furnished to the Securities and Exchange Commission or its staff upon request.
Exhibit 99(a)



Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002



In connection with the filing of this Annual Report on Form 10-K for the year
Ended December 31, 2002 (the Report) by CompuCom Systems, Inc. (Registrant), the undersigned hereby certifies that:



| | 1. |  | The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities
Exchange Act of 1934, as amended, and
| | -- |  | ---------------------------------------------------------------------------------------------------------------------------------



| | 2. |  | The information contained in the Report fairly presents, in all material respects, the
financial condition and results of operations of Registrant.
| | -- |  | ---------------------------------------------------------------------------------------------------------------------------------------------------



/s/ J. Edward Coleman

J. Edward Coleman,

Chairman of the Board, President,

Chief Executive Officer,
and Director



1
----

**EXHIBIT 5A**

**CONSENT OF INDEPENDENT ENGINEERS**

 We refer to our report of January 29, 2004, Evaluation of  the Canadian Oil and Gas Reserves of TransGlobe Energy Corporation (the “Company”)  as of December 31, 2003 (the “Report”). 

 We hereby consent to references to our name in the Company’s  Annual Report on Form 40-F to be filed with the United States Securities and  Exchange Commission pursuant to the Securities Exchange Act of 1934, as amended.  We also confirm that we have read the Company’s Annual Information Form  for the year ended December 31, 2003 dated May 14, 2004 and that we have no  reason to believe that there are any misrepresentations in the information contained  in it that was derived from the Report or that is within our knowledge as a  result of the services we performed in connection with such Report. 

 Sincerely, 

 DeGolyer and MacNaughton Canada Limited   (formerly Outtrim Szabo Associates Ltd.) 

*s/s**Colin Outtrim***

 Name    Colin P. Outtrim   Title:     Senior Vice President 

 Calgary, Alberta, Canada   May 14, 2004 

----

**EXHIBIT 5B**

**CONSENT OF INDEPENDENT ENGINEERS**

 We refer to our reports of January 20, 2004, Interests of  TransGlobe Energy Corporation (the “Company”) in An Nagyah Field,  Damis Block S-1, Yemen and the Evaluation of the Interests of TransGlobe Energy  Corporation Tasour Field, Howarime Block 32, Yemen as of December 31, 2003 (the  “Report”). 

 We hereby consent to references to our name in the Company’s  Annual Report on Form 40-F to be filed with the United States Securities and  Exchange Commission pursuant to the Securities Exchange Act of 1934, as amended.  We also confirm that we have read the Company’s Annual Information Form  for the year ended December 31, 2003 dated May 14, 2004 and that we have no  reason to believe that there are any misrepresentations in the information contained  in it that was derived from the Report or that is within our knowledge as a  result of the services we performed in connection with such Report. 

 Sincerely, 

 Fekete Associates Inc. 

*s/s Gary D. Metcalfe*Name:   Gary D. Metcalfe   Title:     Vice President, Evaluations 

 Calgary, Alberta, Canada   May 14, 2004 

----
From: gregdodd@charter.net

To: E-OHPSCA2713.EBSA

Subject: Comment: RIN 1210-AB44

Date: Wednesday, September 07, 2011 1:04:12 PM

To Whom It May Concern:

I am writing today to ask in the strongest way possible that you rescind the unjust and coercive

mandate that all "contraceptives" and sterilization procedures be covered by private health insurance

with no co-pay to patients. If you do not reverse course I ask you to expand conscience protections for

any organizations that provide individual and group insurance and have moral or religious objections. I

strongly oppose the government forcing free insurance coverage on Americans especially for drugs and

devices that I oppose because some of these can cause an abortion (such as ella and Plan B).

I also ask you to reconsider your definition of religious employer and offer an authentic conscience

protection for any organization and business that has moral or religious objection to providing such

insurance to their employees. This legal mandate clearly violates the spirit of conscience laws which

prohibit government discrimination against those who object to various health services on moral or

religious grounds. The definition of "religious employer" in the regulation is so narrow as to only include

churches, but will still mean that a host of businesses and organizations that have conscience objections

will be required to choose between either violating their conscience or not being able to offer employees

health insurance.

Please protect the conscience rights of insurers, providers and people like me who object to being

forced by the federal government to offer or subsidize contraceptives and sterilization services, especially

when some of these drugs can take the life of early unborn children. No Americans should be forced by

the federal government to essentially subsidize services they object to. I again urge you in the strongest

way possible to reverse course and remove contraceptives and sterilizations from the list of mandatory

preventive services.

Sincerely,

Greg Dodd

Whitehall, MI 49461
No. 218, Misc.

#### Holland *v.*New York.

Court of Appeals of New York. Certiorari denied.
From: mamaluke35@aol.com

To: E-OHPSCA2713.EBSA

Subject: Comment: RIN 1210-AB44

Date: Wednesday, September 07, 2011 1:08:43 PM

To Whom It May Concern:

I am writing today to ask in the strongest way possible that you rescind the unjust and coercive

mandate that all "contraceptives" and sterilization procedures be covered by private health insurance

with no co-pay to patients. If you do not reverse course I ask you to expand conscience protections for

any organizations that provide individual and group insurance and have moral or religious objections. I

strongly oppose the government forcing free insurance coverage on Americans especially for drugs and

devices that I oppose because some of these can cause an abortion (such as ella and Plan B).

I also ask you to reconsider your definition of religious employer and offer an authentic conscience

protection for any organization and business that has moral or religious objection to providing such

insurance to their employees. This legal mandate clearly violates the spirit of conscience laws which

prohibit government discrimination against those who object to various health services on moral or

religious grounds. The definition of "religious employer" in the regulation is so narrow as to only include

churches, but will still mean that a host of businesses and organizations that have conscience objections

will be required to choose between either violating their conscience or not being able to offer employees

health insurance.

Please protect the conscience rights of insurers, providers and people like me who object to being

forced by the federal government to offer or subsidize contraceptives and sterilization services, especially

when some of these drugs can take the life of early unborn children. No Americans should be forced by

the federal government to essentially subsidize services they object to. I again urge you in the strongest

way possible to reverse course and remove contraceptives and sterilizations from the list of mandatory

preventive services.

Sincerely,

Helen Capelli-Brehm

Elverson, PA 19520
From: denisan777@aol.com

To: E-OHPSCA2713.EBSA

Subject: Comment: RIN 1210-AB44

Date: Wednesday, September 07, 2011 12:26:42 PM

To Whom It May Concern:

I am writing today to ask in the strongest way possible that you rescind the unjust and coercive

mandate that all "contraceptives" and sterilization procedures be covered by private health insurance

with no co-pay to patients. If you do not reverse course I ask you to expand conscience protections for

any organizations that provide individual and group insurance and have moral or religious objections. I

strongly oppose the government forcing free insurance coverage on Americans especially for drugs and

devices that I oppose because some of these can cause an abortion (such as ella and Plan B).

I also ask you to reconsider your definition of religious employer and offer an authentic conscience

protection for any organization and business that has moral or religious objection to providing such

insurance to their employees. This legal mandate clearly violates the spirit of conscience laws which

prohibit government discrimination against those who object to various health services on moral or

religious grounds. The definition of "religious employer" in the regulation is so narrow as to only include

churches, but will still mean that a host of businesses and organizations that have conscience objections

will be required to choose between either violating their conscience or not being able to offer employees

health insurance.

Please protect the conscience rights of insurers, providers and people like me who object to being

forced by the federal government to offer or subsidize contraceptives and sterilization services, especially

when some of these drugs can take the life of early unborn children. No Americans should be forced by

the federal government to essentially subsidize services they object to. I again urge you in the strongest

way possible to reverse course and remove contraceptives and sterilizations from the list of mandatory

preventive services.

Sincerely,

Denisa Newton

Bristow, OK 74010
### PREFLIGHT CHECKLIST

 AREA OF FLIGHT

................................ .. CHECK FOR HAZARDS

 BATTERY LEVEL S

................................ CHECK (A/C, REMOTE, AND TABLET)

 PROPS

................................ ....................... CHECK AND SECURE

 LENS FILTER

................................ .......... CHECK

 REMOTE CONTROL

.............................. ON

 TABLET IN AIRPLANE MODE

............ CONFIRM

 FLIGHT MOD E SWITCH

...................... P

– Mode

 A/C POWER

................................ .............. O N

 DJI PILOT APP

................................ ........ ON AND CONNECTED

o ON SCREEN FLIGHT MODE

....... CONFIRM P

- ATTI & SAFE TO FLY

o A/C BATTERY STATUS

.................. CHECKED

o FREQUENCIES.........................CHECK

 COMPASS

................................ ................. CALIBRAT E

 GPS SIGNAL

................................ ............ AQUIRED (FLASHING GREEN)

 HOME POINT

................................ .......... SET

 GI MBAL MODE

................................ ...... SET

 CAMERA SETTINGS

.............................. SET

 AREA

................................ ......................... CLEAR

 MOTORS

................................ ................... ARM

 FLIGHT CONTROLS

.............................. CHECKED

 TAKEOFF

................................ ................. ACCOMPLISH

 LANDING GEAR

................................ ..... UP



### POSTFLIGHT CHECKLIST

 A/C

................................ .............................. DISARM

 A/C POWER

................................ .............. OFF

 REMOTE POWER

................................ ... OFF

 PROPS

................................ ....................... REMOVE / INSPECT

 MOTORS

................................ ................... CHECK FREE AND CLEAR

 AIRFRAME

................................ ............... INSPECT
EXHIBIT 31.1
                            CERTIFICATION PURSUANT TO
                  SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Richard Starke, President of Lotus Capital Corp.certify that:

1. I have reviewed this annual report on Form 10-KSB of Lotus Capital Corp.;

2. Based on my knowledge, this report does not contain any untrue statement of a
material fact or omit to state a material fact necessary to make the statements
made, in light of the circumstances under which such statements were made, not
misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial
information included in this report, fairly present in all material respects the
financial condition, results of operations and cash flows of the small business
issuer as of, and for, the periods presented in this report;

4. The small business issuer's other certifying officer(s) and I are responsible
for establishing and maintaining disclosure controls and procedures (as defined
in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the small business issuer and
have:

(a) Designed such disclosure controls and procedures, or caused such disclosure
controls and procedures to be designed under our supervision, to ensure that
material information relating to the small business issuer, including its
consolidated subsidiaries, is made known to us by others within those entities,
particularly during the period in which this report is being prepared;

(b) Evaluated the effectiveness of the small business issuer's disclosure
controls and procedures and presented in this report our conclusions about the
effectiveness of the disclosure controls and procedures, as of the end of the
period covered by this report based on such evaluation; and

(c) Disclosed in this report any change in the small business issuer's internal
control over financial reporting that occurred during the small business
issuer's most recent fiscal quarter (the small business issuer's fourth fiscal
quarter in the case of an annual report) that has materially affected, or is
reasonably likely to materially affect, the small business issuer's internal
control over financial reporting; and

5. The small business issuer's other certifying officer(s) and I have disclosed,
based on our most recent evaluation of internal control over financial
reporting, to the small business issuer's auditors and the audit committee of
the small business issuer's board of directors (or persons performing the
equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or
operation of internal control over financial reporting which are reasonably
likely to adversely affect the small business issuer's ability to record,
process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other
employees who have a significant role in the small business issuer's internal
control over financial reporting.

 Dated: April 11, 2005

 /s/ Richard Starke
 ------------------
 Richard Starke
 President
 (Principal Executive Officer)
<PAGE>
                                                                    Exhibit 32.1

                CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350
                      AS ADOPTED PURSUANT TO SECTION 906 OF
                         THE SARBANES-OXLEY ACT OF 2002

     In connection with the Quarterly Report of Select Medical Corporation (the
"Company") on Form 10-Q for the quarter ended March 31, 2006 as filed with the
Securities and Exchange Commission on the date hereof (the "Report"), I, Robert
A. Ortenzio, Chief Executive Officer of the Company, certify, pursuant to 18
U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of
the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material
respects, the financial position and results of operations of the Company.

Date: May 15, 2006


                                        /s/ Robert A. Ortenzio
                                        ----------------------------------------
                                        Robert A. Ortenzio
                                        Chief Executive Officer
```

[Congressional Bills 110th Congress]
[From the U.S. Government Publishing Office]
[H. Res. 1363 Engrossed in House (EH)]

                In the House of Representatives, U. S.,

                                                         July 23, 2008.
    Resolved, That upon adoption of this resolution it shall be in order to take 
from the Speaker's table the bill (H.R. 3221) to provide needed housing reform 
and for other purposes, with the Senate amendment to the House amendments to the 
Senate amendment thereto, and to consider in the House, without intervention of 
any point of order, a motion offered by the chairman of the Committee on 
Financial Services or his designee that the House concur in the Senate amendment 
to the House amendment numbered 1 with the amendment printed in the report of 
the Committee on Rules accompanying this resolution. The Senate amendment and 
the motion shall be considered as read. The motion shall be debatable for two 
hours, with 80 minutes equally divided and controlled by the chairman and 
ranking minority member of the Committee on Financial Services and 40 minutes 
equally divided and controlled by the chairman and ranking minority member of 
the Committee on Ways and Means. The previous question shall be considered as 
ordered on the motion to its adoption without intervening motion.
    Sec. 2.  Upon adoption of the motion specified in the first section of this 
resolution, the House shall be considered to have receded from any remaining 
amendments or disagreements.
    Sec. 3.  During consideration of the motion to concur pursuant to this 
resolution, notwithstanding the operation of the previous question, the Chair 
may postpone further consideration of the motion to such time as may be 
designated by the Speaker.
            Attest:

                                                                          Clerk.
```
EXHIBIT
      32.1











CERTIFICATION
OF PRINCIPAL EXECUTIVE OFFICER


PURSUANT
TO 18 U.S.C. SECTION 1350





AS
ADOPTED PURSUANT TO


SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002











In
connection with the Annual Report on Form 10-K/A of First Keystone Corporation
(the “Corporation”) for the period ended December 31, 2009, as filed with the
Securities and Exchange Commission (the “Report”), I, J. Gerald Bazewicz,
President and CEO, certify, pursuant to 18 U.S.C. Section 1350, as added by
Section 906 of the Sarbanes-Oxley Act of 2002, that to my
knowledge:





1.
            The
      Report fully complies with the requirements of Section 13(a) or 15(d) of
      the Securities Exchange Act of 1934;
and





2.
            The
      information contained in the Report fairly presents, in all material
      respects, the financial condition and results of operations of the
      Corporation as of and for the period covered by the
  Report.








/s/
      J. Gerald BazewiczJ.
      Gerald BazewiczPresident
      and CEO








May 20,
2010